Lahera Alonso, A., Vela Martín, L., Fernández Navarro, P., Llamas Sillero, P., López Lorenzo, J. L., Cornago, J., . . . Villa Morales, M. d. C. (2024). PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.
Citação norma ChicagoLahera Alonso, Antonio, Laura Vela Martín, Pablo Fernández Navarro, Pilar Llamas Sillero, José Luis López Lorenzo, Javier Cornago, Francisco Javier Santos Hernández, José Fernández Piqueras, y María del Consuelo Villa Morales. PIM1 Is a Potential Therapeutic Target for the Leukemogenic Effects Mediated By JAK/STAT Pathway Mutations in T-ALL/LBL. 2024.
Citação norma MLALahera Alonso, Antonio, et al. PIM1 Is a Potential Therapeutic Target for the Leukemogenic Effects Mediated By JAK/STAT Pathway Mutations in T-ALL/LBL. 2024.